FDA Authorizes Marketing of the First Genetic Test to Aid in the Diagnosis of Fragile X Syndrome
22 Febbraio 2020
The U.S. Food and Drug Administration has authorized marketing of the first test to detect a genetic condition known as Fragile X Syndrome (FXS), the
